Background This study was to explore the infiltration pattern of immune cells in the prostate
cancer (PCa) microenvironment and evaluate the possibility of specific infiltrating immune …

Background Some historic breakthroughs have been made in immunotherapy of advanced
cancer. However, there is still little research on immunotherapy in prostate cancer. We …

Prostate cancer (PCa) is the most commonly diagnosed malignancy and the second leading
cause of cancer-related death in American men. Androgen deprivation therapy (ADT) has …

Prostate cancer (PCa) is one of the most common malignancies in male. We aim to establish
a novel gene signature for immune infiltration and outcome (biochemical recurrence (BCR) …

Background The study of the immune microenvironment in prostate cancer (PRAD) has
brought new opportunities for the current traditional treatment regimens. Therefore, our goal …

Abstract Grade group 4 and 5 (GG-45) prostate cancer (PCa) patients are at the highest risk
of lethal outcomes, yet lack genomic risk stratification for prognosis and treatment selection …

Background There is significant heterogeneity in prostate cancer (PCa), but immune status
can reflect its prognosis. This study aimed to explore immune-related gene-based novel …

Prostate cancer (PCa) is the fifth leading cause of death from cancer in men worldwide. Its
treatment remains challenging due to the heterogeneity of the tumor, mainly because of the …

Prostate cancer (PCa) is a urological malignancy with poor prognosis. Immune-related
genes are associated with immune infiltration in prostate cancer, but their role in …

Introduction Prostate cancer is a common cancer among male population. The aberrant
expression of histone modifiers has been identified as a potential driving force in numerous …